Page 4 - Compulsory Licensing News Today

Comments Two Indian states, Maharashtra and Jharkhand, have requested for permission to import Remdesivir, the anti-viral drug from Bangladesh. With COVID cases exploding all over the country, particularly in major urban centres in Maharashtra, Delhi and other states, the frantic effort to source Remdesivir from all available sources has acquired greater momentum. Remdesivir is the only drug approved so far, for the treatment of COVID patients in life-threatening stages. Though not a silver bul...

Singh’s counsel 1 min read Share Via Read Full Story In suggestions on fighting covid reportedly made on Sunday to Prime Minister Narendra Modi, his predecessor Manmohan Singh said the government should state the quantity of vaccines ordered, the delivery schedule, and how these would be distributed for states to plan better. Also, states should have the flexibility to decide jab-eligibility criteria, and vaccine makers should be supported with funds and other aid to expand capacity and raise...

Supplemental. 128A. (1) In this Act a “compulsory pharmaceutical licence” means a compulsory licence granted under Regulation (EC) No 816/2006 of the European Parliament and of the Council of 17 May 2006 on compulsory licensing of patents relating to the manufacture of pharmaceutical products for export to countries with public health problems12 (referred to in this Act as “the Compulsory Licensing Regulation”). (2) In the application to compulsory pharmaceutical licences of the provis...

the Patents Act 2004 the Intellectual Property (Enforcement, etc.) Regulations 2006 the Patents (Compulsory Licensing and Supplementary Protection Certificates) Regulations 2007 the Legal Services Act 2007 the Crime and Courts Act 2013 the Enterprise and Regulatory Reform Act 2013(Competition) (Consequential, Transitional and Saving Provisions) Order 2014 the Copyright (Public Administration) Regulations 2014 the Intellectual Property Act 2014 the Legislative Reform (Patents) Order 2014 the Pat...